28 August 2025
Sun Life Malaysia joins forces with BookDoc, Health Lane Family Pharmacy, Roche Diagnostics Malaysia, and MOG Eyewear Malaysia to promote early diabetes prevention.
Tag: diabetes
30 June 2025
Biocon Biologics’ partnership with the Malaysian government exemplifies a successful model for building a resilient biotech ecosystem by driving innovation, developing local talent, enabling better patient outcomes, and advancing insulin self-sufficiency in Malaysia.
29 May 2025
At AMSA-UPM's Diabetes Day 2025 event, an MOH official says diabetes is not only a medical issue, but a social one. "The solution requires a cross-sectoral approach involving education policies, urban planning, community engagement, and economic support."
7 February 2025
This collaboration reinforces a shared commitment to improve access to essential diabetes care products, education, and support for underprivileged Type 1 and Type 2 diabetes patients.
18 November 2024
Letter
Diabetes In Malaysia: Breaking Down Barriers To Health And Bridging Gaps In Care — Dr Ruthashini Selvasingam, Dr Tan Cia Vei & Prof Dr Moy Foong Ming
The latest National Health and Morbidity Survey (NHMS) 2023 indicates that 15.6 per cent of Malaysian adults are affected by diabetes. Nearly one in six Malaysians now lives with this chronic disease.
14 November 2024
Malaysia
Malaysians Getting Diabetes In Their 20s, Delay To 50s Possible By Managing Prediabetes: Expert
An endocrinologist says Malaysians are getting diabetes before age 40, unlike diabetes onset in one's 50s in other countries. One can delay diabetes to middle age by managing prediabetes. Diabetes isn't just about sugary drinks, but eating excessive carbs.
18 October 2024
For Budget 2025, PM Anwar Ibrahim announces an increase in the sugary-sweetened beverage (SSB) tax rate by 40 sen/ litre. This revenue will be used to support additional allocations for SGLT2 inhibitors to treat diabetes and peritoneal dialysis services.
2 September 2024
Denmark's Novo Nordisk – which currently supplies 20% of MOH's human insulin supply – says its supply of human insulin to Malaysia has remained stable and it will continue its supply to the country. Novo Nordisk is also in an ongoing dialogue with MOH.
28 August 2024
MCA's Dr Pamela Yong tells MOH to acknowledge the human insulin shortage crisis, saying alternative diabetes treatments like insulin analogs and oral medications are a temporary fix. She adds, insulin shortages can lead to severe complications like DKA.
26 August 2024
Dr Dzul says India's Biocon Biologics, which runs a Johor manufacturing plant, failed its human insulin supply contractual obligations. He adds the current human insulin supply can last till year end, dismissing an "alarmist" scenario of the shortage.